Replimune Group Inc (NASDAQ:REPL), a biotechnology company specializing in oncolytic immunotherapy for cancer treatment with a current market capitalization of $803 million, has been making ...

Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company at the forefront of precision genetic medicines with a market capitalization of $1.87 billion, is navigating a critical juncture in its ...

Adani group stocks surged as news of Hindenburg Research's closure emerged, alongside positive developments in the ...

The big three U.S. equity indexes were modestly lower Thursday, but small caps were bucking the trend. The Russell 2000 index was up 0.1% in the final hour of trade, but also outperforming its ...

The fund’s strategy, top holdings, and recent portfolio moves are explored to provide insights for existing and potential ...

The fund’s strategy, top holdings, and recent portfolio moves are explored to provide insights for existing and potential ...

Sarepta Therapeutics' Elevidys for DMD shows revenue potential, with market cap justified at $11.4bn and potential for >50% ...

Global equity markets have grown more concentrated, led by the U.S. and a few dominant stocks. Click here to read the full ...

Action in potential 'pump and dump' case as market capitalisation surges to Rs 4,000 crore from Rs 40 crore in just 8 months ...

Shiba Inu has been attracting considerable attention in cryptocurrency, with predictions indicating its market cap value ...

Despite the risks, these platforms will continue to offer opportunities for investors willing to navigate the competitive ...

Capital Group on Thursday launched its first exchange-traded fund designed to track small and mid-cap U.S. stocks, a segment of the ETF market where new fund launches remain relatively rare.